Clinical trials are key to determining the safety and efficacy of medicines. But to do so, trials must be robust and ethical—and their full results must be reported publicly. Unfortunately, many trials are not meeting this criteria. More and more are being off-shored to developing countries where they can be conducted more cheaply and with questionable ethical standards.
by TESSEL MELLEMA and ALIÉNOR DEVALIÈRE, EU Policy Advisors
(UPDATE at 5:15 p.m. on 9 June: The European Parliament vote on TTIP has been postponed to a later date.)
It’s going to be a big day in Strasbourg tomorrow (10 June) as Members of the European Parliament vote on the Transatlantic Trade and Investment Partnership (TTIP) resolution.